AstraZeneca has partnered with the Ayala-controlled AC Health to use some of the latter’s hospitals as sites for medical ...

The Etcamah results came a week after the U.S. granted approval for the drug for advanced breast cancer upon the detection of ...

Pharmaceutical giant AstraZeneca is expanding its clinical trial footprint in the Philippines by tapping the Ayala Group’s health-care arm to identify and prepare ...

The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales ...

AstraZeneca Philippines and AC Health, through Healthway Medical Network, have signed a memorandum of understanding (MOU) to ...

It has been a mixed few days for AstraZeneca's oncology pipeline, as two drugs in its lung cancer portfolio have secured a ...

AstraZeneca Philippines and AC Health have signed a memorandum of understanding to establish a pioneering partnership aimed ...

UBS has told investors that the recent slide in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares has gone too far, keeping its ...

The year’s biggest meeting on lung cancer research featured data suggesting a new treatment standard for an aggressive tumor as well as debate about the reliability of results from China-run studies.

A committee said the volrustomig combination was unlikely to reach either of the primary endpoints for the trial, but the ...

The ink was barely dry on the FDA approval letter for AstraZeneca’s Etcamah before the oral SERD suffered a key clinical ...

AstraZeneca may have included outdated information from its COVID-19 vaccine clinical trial, the Data and Safety Monitoring Board said late Monday. The outdated information may have provided an ...